Jul 17, 2006
1:2
For every 2 shares held, investors received 1.
The split itself did not change the total investment value.
10x Genomics, Inc. (NASDAQ:TXG) operates in the Biotechnology industry.
10x Genomics, Inc. company overview10x Genomics, Inc.'s most recent stock split was on July 17, 2006. It was a 1-for-2 reverse split, so shareholders received 1 share for every 2 they held.
10x Genomics, Inc. has split its stock once. This history records one reverse split, on July 17, 2006.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In 10x Genomics, Inc.'s 1-for-2 reverse split on July 17, 2006, every 2 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
10x Genomics, Inc. has not announced a new split in our records. Its most recent split was on July 17, 2006, 20 years ago. Companies announce splits in advance, and any new NASDAQ:TXG split will appear on this page.